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Copper Oxide Nanoparticle Diameter Mediates
Serum-Sensitive Toxicity in BEAS-2B Cells
Angie S. Morris, Brittany E. Givens, Aaron Silva, and Aliasger K. Salem*
1. Introduction
Nanoparticles (NPs) are abundantly used in commercial
processes and consumer products. Among the most common
NPs are CuO NPs, which are used in cosmetics, sensors,
catalysis, and antimicrobials.[1,2] CuO NPs belong in the metal
oxide NP class, which are known to readily
dissociate into their component ions in
aqueousmedia.[3–6] Copper dust causes tox-
icity when inhaled, and there are reports
that copper in cigarette smoke causes
inflammatory responses in the lungs.[7]
The ability for CuO NPs to elicit the same
response as copper dust is still under inves-
tigation. Previous research findings
include that CuO exposure can induce reac-
tive oxygen species and induce double
strand breaks in DNA, which may lead to
cancer.[6,8–11]
Although CuO NP toxicity has been
widely studied in vitro, discrepancies
between studies still exist. These discrepan-
cies result from the cell line, cell culture
method, and NP dissociation into
ions.[1,6,9,12–18] The most common cell line
used for toxicological investigations is A549
cells, which proliferate quickly and are an
established lung toxicity model.[4,15,18,19]
A549 cells were derived from an adenocar-
cinoma of alveolar cells. In contrast, BEAS-
2B bronchial epithelial cells were obtained from a noncancerous
source and are therefore considered a strong alternative to A549
cells for toxicity testing. BEAS-2B cells readily undergo squa-
mous differentiation in the presence of as little as 2% serum,
and therefore must be cultured in media that contain little to
no fetal bovine serum (FBS).[20,21] Even so, many studies with
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Copper oxide (CuO) nanoparticles (NPs) are abundant in manufacturing
processes, but they are an airway irritant. In vitro pulmonary toxicity of CuO NPs
has been modeled using cell lines such as human bronchial epithelial cell line
BEAS-2B. In 2D in vitro culture, BEAS-2B undergoes squamous differentiation
due to the presence of serum. Differentiation is part of the repair process of lung
cells in vivo that helps to preserve the epithelial lining of the respiratory tract.
Herein, the effects of serum on the hydrodynamic diameter, cellular viability,
cellular differentiation, and cellular uptake of 5 and 35 nm CuO NPs are
investigated, and the mean cell area is used as the differentiation marker for
BEAS-2B cells. The results demonstrate that the hydrodynamic diameter
decreases with the addition of serum to the culture medium. Serum also
increases the mean cell area, and only affects dose-dependent cytotoxicity of
35 nm CuO NPs, while simultaneously having no effect on intracellular Cu2þ.
This study presents evidence that both NP size and the presence of serum in
culture media influence the relative viability of BEAS-2B cells following CuO NP
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BEAS-2B cells and nanotoxicity utilize over 2% serum in the
cell culture medium, potentially causing conflicting results
(Figure 1).[22–44]
In the current study, we sought to address these discrepancies
with NP toxicity in BEAS-2B cells by utilizing CuO NPs of two
different sizes and varying amounts of FBS in the cell culture
media. We investigated if these discrepancies were a result of
changes in hydrodynamic diameter or differences in intracellular
uptake of CuO NPs due to the presence of serum. All studies
were conducted with LHC-9 medium, which was designed spe-
cifically for BEAS-2B cell culture.[21] We also used the mean cell
area as a differentiation marker by culturing cells in LHC-9
medium containing FBS independent of CuO NP exposure.
Through these investigations, we noted that there are NP
size–dependent effects on cell viability and NP uptake as well
as serum effects on the aforementioned parameters.
2. Results
2.1. Serum Influenced NP Size Distributions in Aqueous
Solution
Two differently sized CuO NPs were characterized using trans-
mission electron microscopy (TEM) and X-ray diffraction (XRD)
for size and elemental analysis. These CuO NPs were also char-
acterized in serum-free and serum-containing media using
dynamic light scattering and laser Doppler velocimetry. The
manufacturer specifications for the CuO NPs reported the sizes
as 4 and 24 nm; however, micrographs and ImageJ analyses
revealed that the measured particle sizes were 5 1 and
35 19 nm, respectively (Figure 2).
CuO NP aggregation in the cell culture medium with varying
concentrations (%v/v) of FBS was assessed with data from a
Malvern Zetasizer (Table 1). The hydrodynamic diameters of
small (5 nm) versus large (35 nm) NPs in LHC-9 medium alone
(0% FBS) were significantly different from one another
(p< 0.0001), with values indicating that particles of 5 and
35 nm have different aggregation behavior in the cell culture
medium. The same was true when 10% FBS was present in
the LHC-9 medium (p< 0.05).
The 5 nm NPs had significantly different hydrodynamic diam-
eters (p< 0.01) between 0% FBS and 10% FBS, but none of the
smaller incremental changes were significantly different. The
aggregate diameter had an inverse relationship with the FBS con-
centration. As FBS increased, the hydrodynamic diameter
decreased. These diameters ranged from 15 times (10% FBS)
to 65 times (0% FBS) the diameter of an individual particle.
The 35 nm NPs had significantly lower hydrodynamic diameters
(p< 0.05) between 0% FBS and all other FBS concentrations.
Unlike the 5 nmNPs, the 35 nmNPs decreased in hydrodynamic
diameter from 0% FBS to 1% FBS, and then the hydrodynamic
diameters remained fairly consistent at all other FBS
concentrations.
In addition to the hydrodynamic diameter, the PDI for each
sample was measured to ascertain the spread of the data. PDI
close to 1 indicates that samples are polydisperse and consist
of a wide range of sample variability. The PDI was highest in
the absence of FBS for both 5 and 35 nm CuO NPs. The PDI
in the presence of FBS was relatively consistent for the 35 nm
CuO NPs at all percentages of FBS. For the 5 nm CuO NPs,
5% and 10% FBS had similar PDIs, which were lower than
the PDI with 1% FBS.
2.2. Serum Did Not Alter the 2D Mean Cell Area after In Vitro
Culture
The impact of serum on BEAS-2B squamous differentiation was
assessed using mean cell area comparisons before and after incu-
bation with FBS in the cell culture medium. Cells were incubated
in LHC-9 medium containing 0% FBS (control) and 1–10% FBS
for up to 72 h (Table 2). Changes in mean cell area were not
Figure 1. Media used for BEAS-2B NP investigations in 2019. Obtained
from PubMed search of “Beas-2B” and “Nanoparticle”. BEGM: bronchial
epithelial growth medium; RPMI: Roswell Park Memorial Institute;
DMEM: Dulbecco’s Modified Essential Medium; BEBM: bronchial epithe-
lial basal medium.
Figure 2. TEM images of A) 4 nm and B) 24 nm CuONPs and C) their size
distribution. The size distribution was obtained by analyzing images using
ImageJ software. Upon obtaining these results, it was discovered that the
4 nm particles had a mean size of 5 nm and 24 nm particles had a mean
size of 35 nm. These measured mean sizes are used for reference in this
article. This figure has been previously published as part of a Ph.D. dis-
sertation. Reproduced with permission.[58] 2017, ProQuest.
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significant, although the increase peaked at 48 h and declined at
72 h for most FBS concentrations. Specifically, from 0 to 48 h,
FBS concentrations of 1% and 5% resulted in an increase in
mean cell area and resulted in a decrease in mean cell area from
48 to 72 h. Cells incubated with 10% FBS exhibited the largest
drop in mean cell area in the last 24 h, whereas 1% and 2%
FBS in the cell culture media resulted in the largest increase
in the mean cell area within the first 24 h. The only concentration
with an increase in mean cell area between 48 and 72 h of incu-
bation was 0% FBS, the control group.
2.3. Culturing with Serum Affected the Relative Cell Viability for
35 nm CuO NPs
At a constant Cu2þ concentration of 40 μgmL1, the effects of
serum concentration on relative cell viability could readily be
examined. Increasing the concentration of FBS in the LHC-9
media decreased the relative cell viability for 35 nm NPs, but
did not for 5 nm CuO NPs or copper nitrate (Figure 4). In fact,
the relative cell viability for 5 nm CuO NPs and copper nitrate
decreased to 71% for NPs and 56% for copper nitrate with no
FBS and increased back to 101% for 5 nm CuO NPs in just
1% FBS–containing media and 101% for copper nitrate in 2%
FBS–containing media.
The dose-dependent response for Cu2þ was investigated for
cells cultured in LHC-9 medium with 0% FBS or 10% FBS
(Figure 3). When there was no FBS in the culture medium, nei-
ther the 5 nm CuO NPs nor the 35 nm CuO NPs reduced the
relative cell viability to or below 50%. For cells cultured in
LHC-9 medium with 10% FBS, the 5 nm CuO NPs reduced cell
viability to 51% at 100 μgmL1 Cu2þ, and the 35 nm CuO NPs
reduced cell viability to 9% at 20 μgmL1 Cu2þ and 4–5% for
40–100 μgmL1 Cu2þ. In the absence of FBS, copper nitrate
appeared to have a positive effect on the relative cell viability, rais-
ing it above 100% up to 20 μgmL1 Cu2þ, and then decreasing it
sharply down to 54% at 40 μgmL1 Cu2þ and further to 13% at
100 μgmL1 Cu2þ. In the presence of 10% FBS, copper nitrate
increased the relative viability above 100% up to 40 μgmL1
Cu2þ and then down to 34% at 60 μgmL1 and 6% at
100 μgmL1.
2.4. Intracellular Cu2þ Was Altered by NP Diameter and Serum
The amount of internalized copper was measured using induc-
tively coupled plasma mass spectrometry (ICP-MS) to determine
the influence of the NP diameter and serum concentration on NP
uptake by BEAS-2B cells. The observed intracellular Cu2þ was
200 times larger for BEAS-2B cells exposed to 35 nm NPs com-
pared with 5 nm CuO NPs. The addition of serum significantly
increased intracellular Cu2þ for 5 nm CuO NPs from 0% to 3%
serum (p¼ 0.0028) and for 35 nm CuO NPs from 3% to 10%
serum (p< 0.0001). All other p-values from multiple compari-
sons are provided in Table S6, Supporting Information.
3. Discussion
The BEAS-2B cell line was initially developed by infecting pri-
mary human bronchial epithelial cells (HBECs) with adenovirus
12-SV40 to increase the lifespan to assess aging, differentiation,
and carcinogenesis of normal HBECs in the 1980s[20,21,45,46] and
is currently a common choice as an in vitro lung model of nano-
toxicity.[47–49] BEAS-2B cells were observed to undergo squamous
differentiation in the presence of 2% FBS, spurring the develop-
ment of serum-free culture media such as LHC-9 and BEGM.[21]
Even so, many reports utilize RPMI[31,50–52] or DMEM[32,41,53,54]
with up to 10% FBS. These FBS concentrations raise concerns
Table 2. The normalizedmean cell size determined from image analysis of
BEAS-2B cells upon incubation with FBS (0–10% v/v) from 0 to 72 h. Data
were normalized to time zero, with increases in mean represented as
values greater than one and decreases as values between zero and
one. The mean (n¼ 3) and standard deviation are reported from three
experimental replicates with each replicate averaged from a minimum
of 100 cells. Statistical analysis was performed using nested one-way
ANOVA grouping based on time. No significant differences were
observed. (Please refer to Table S2, Supporting Information, for
summary of p-values.).
% FBS [v/v] 0 h 24 h 48 h 72 h
0 1 0 0.94 0.27 0.92 0.27 1.08 0.14
1 1 0 1.14 0.10 1.18 0.14 1.14 0.09
2 1 0 1.17 0.06 1.14 0.06 1.18 0.15
5 1 0 1.02 0.15 1.10 0.19 1.05 0.18
10 1 0 1.02 0.11 1.08 0.21 0.91 0.25
Table 1. The hydrodynamic diameter and the polydispersity index (PDI) of 5 and 35 nm CuO NPs in culture media with varying levels of FBS. The average
and standard deviation are reported for n¼ 3. Statistical significance was assessed by comparing to LHC-9 with 0% FBS.
5 nm CuO NPs 35 nm CuO NPs
Mean
diameter SD [nm]
PDI SD [nm] Mean
diameter SD [nm]
PDI SD [nm]
% FBS 0 326 27***a) 0.70 0.20 648 56***a) 0.30 0.10
1 232 96 0.60 0.20 284 50***b) 0.23 0.03
5 210 117 0.40 0.10 297 44***b) 0.27 0.05
10 74 28**a),b) 0.40 0.10 300 138***a),b) 0.23 0.05
a)Significant differences between 5 and 35 nm particles. Replicative symbols indicate level of significance with: *p< 0.05, **p< 0.01, ***p< 0.001, and ***p< 0.0001. A
summary of exact p-values is presented in Table S1, Supporting Information; b)Significantly different from 0% FBS.
www.advancedsciencenews.com www.advnanobiomedres.com
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about squamous differentiation in BEAS-2B cells.[43,45,55] In addi-
tion, when addressing NP toxicity, cells cannot differentiate
between primary particle size and aggregate particle size. That
is, the cell “sees” the aggregate size, regardless of what the pri-
mary particle size may be.[1,18,56,57] As such, the NPs used in this
study were characterized not only according to their primary par-
ticle size (Figure 2), but also according to the hydrodynamic
diameter in the LHC-9 medium with varying concentrations
of FBS (Table 1).
Our investigations led to the discovery that serum-containing
media only influence the cellular responses of BEAS-2B cells
when exposed to 35 nm CuO NPs, and not for 5 nm CuO
NPs. The NPs were first characterized according to their primary
diameter and elemental composition. The 5 nm NPs had a
greater tendency toward aggregation than the 35 nm NPs, as evi-
denced by the micrographs (Figure 2).[58] The same 5 nm NPs
also exhibited a uniform, spherical shape, whereas the 35 nm
NPs lacked a distinct morphology. Previously reported X-ray pho-
toelectron spectroscopy (XPS) indicated that copper was in the
same state, Cu(II), for both the small and large NPs, and
XRD indicated that both NPs consisted of a single tenorite
phase.[18] These characterizations confirm that the differences
in the small and large CuO NPs used in this study are restricted
to size and morphology, but not elemental composition.
The aqueous, or hydrodynamic, diameter and PDI were used
to assess the average NP aggregation and dispersity under vary-
ing concentrations of FBS in the culture medium (Table 1). The
results indicated that the 5 nm CuO NPs consistently decreased
in hydrodynamic diameter with increasing FBS concentration,
whereas the 35 nm CuO NPs only decreased in hydrodynamic
diameter between 0% and 1% FBS. These results are consistent
with the existing literature that serum decreases NP aggrega-
tion,[59–62] indicating that regardless of the serum concentration,
the CuO NP aggregate size exposed to the cells is 300 nm.
This then suggests that the observed relative cell viability of
BEAS-2B cells exposed to 35 nm CuO NPs was independent
of the changes in perceived NP diameter (Figure 4). Our previous
work indicated that the smaller NPs were capable of dissolving
into component ions in as little as 1 h, whereas the larger NPs
took 24 h to reach the same Cu2þ concentrations in the
Figure 3. Effect of varying FBS concentration in LHC-9 medium on BEAS-
2B toxicity induced by CuO NPs following 24 h of exposure. The data
points represent the mean (n¼ 8) and error bars are standard deviations
of the mean; two-way ANOVA was performed with multiple comparisons
of means amongst a single FBS concentration across particle types
(Table S3, Supporting Information). Significant differences between
5 nm CuO NPs and Cu(NO3)2 were only noted at 1% FBS
(p< 0.0001). Statistical differences between 35 nm CuO NPs and 5 nm
CuO NPs were always significant (p< 0.0001 at and above 2% FBS)
and between 35 nm CuO NPs and Cu(NO3)2 were noted only for 1%
FBS (p> 0.05); otherwise differences were significant to p< 0.0001.
Figure 4. Effects of NP size and dose on BEAS-2B viability after 24 h of
exposure in 0% or 10% FBS to 5 nm CuO NPs (top), 35 nm CuO NPs
(middle), and copper nitrate (bottom). Data points represent the mean
(n¼ 8) and error bars are the standard deviations of the mean.
Statistical analysis was performed using a two-way ANOVA and multiple
comparisons of means at the same copper concentration and varying par-
ticle type, and the actual p-values are reported in Table S4–S6, Supporting
Information. Significant differences were noted between LHC-9 and
LHC-9þ 10% FBS for 5 nm CuO NPs¼ 39.95 μgmL1, 35 nm CuO
NPs≥ 3.99 μgmL1, and Cu(NO3)2 from 3.99 to 59.92 μg mL1
(inclusive).
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RPMI-1640 medium with 10% FBS.[18] Increases in the FBS con-
centration in LHC-9 medium resulted in decreased relative cell
viability for 35 nm CuO NPs. Both the 5 and 35 nm NPs had
hydrodynamic diameters of 300 nm with 10% FBS in the cul-
ture medium; however, the resultant relative cell viability was
only 13% compared with the control for 35 nm NPs and
105% compared with the control for 5 nm NPs. Similar observa-
tions were made for varying copper II concentrations and com-
paring 0% FBS and 10% FBS in the culture medium (Figure 3).
The copper nitrate and the 5 nm CuO NPs followed similar
trends, in that increasing copper concentration decreased the rel-
ative cell viability at approximately equal rates with both 0% FBS
and 10% FBS. In contrast, BEAS-2B cells were far more sensitive
to the 35 nm CuO NPs when serum was present in the culture
medium. These observations that increased serum increases the
relative viability of cells treated with copper nitrate seems to indi-
cate that copper ions are more toxic to BEAS-2B cells at increas-
ing serum concentrations. Similarly, it was observed that CuO
NPs were more toxic to BEAS-2B cells when there was BSA pres-
ent in the culture medium compared with no BSA.[63] To elimi-
nate the potential effects of NP settling time and delivered
dose,[5,64–66] consistent concentrations of copper II were used
for 5 nm CuO NPs, 35 nm CuO NPs, and copper nitrate.
Therefore, all observed effects are expected to be a result of
NP size and serum concentration. One additional step that could
be taken to further improve the study would be to use an air–
liquid interface (ALI) cell culture system for BEAS-2B cells.[38]
These in vitro systems are particularly advantageous for lung cell
models because they allow for apical exposure of epithelial cells
to air, thus more closely representing the in vivo situation for
epithelial cells in the respiratory tract.[67]
Potential differentiation of BEAS-2B cells was an important
consideration in analyzing these results, in particular in deter-
mining if differentiation in the presence of serum-impacted rel-
ative cell viability. One measure of squamous cell differentiation,
which can occur in response to FBS, is the mean cell area
(Table 2).[20,43,68] This differentiation has additional impacts
in vivo because it functions as the routine repair mechanism
of epithelial defects to assure that the epithelial lining of the
respiratory tract remains intact.[69] Generally, the trends in mean
cell size, which was used as a differentiationmarker in this study,
increased over the first 48 h of incubation. Previous studies have
noted a four-time increase in cell area in the presence of FBS,
particularly due to transforming growth factor-β found in
FBS.[45] In the three days of our study, the control group
increased the mean cell area between 48 and 72 h; however,
all of the cells cultured in FBS exhibited a decreased mean cell
area between 48 and 72 h despite an increase in the first 48 h of
the study. One possible explanation is that confluency impacted
the mean cell area.
The quantity of intracellular copper was measured using ICP-
MS (Figure 5). These results indicated that greater amounts of
copper were present within cells that were exposed to 35 nm
CuO NPs compared with 5 nm CuO NPs, regardless of the
serum concentration. The lack of statistically significant differen-
ces as a function of serum amongst the 5 nm CuO NPs suggests
that any of the observed differences in cytotoxicity as a function
of serum was not due to the amount of Cu2þ within the cells. In
addition, the 5 nm CuO NPs did not exhibit differences in
relative cell viability above 2% FBS. The amount of internalized
copper, which may be the amount of copper in the NPs, likely
influenced the cell viability differences observed between 5 nm
CuO NPs and 35 nm CuO NPs as seen in Figure 3 and 4.
Furthermore, as copper is a micronutrient, we believe that the
lower intracellular copper observed for the 5 nm CuO NPs could
explain the relative cell viabilities at and above 100% compared
with the untreated control.
4. Conclusion
In this study, the interactions between serum and hydrodynamic
diameter, cytotoxicity, and intracellular Cu2þ of 5 and 35 nm
CuO NPs were investigated, as well as the squamous differentia-
tion of BEAS-2B cells in the presence of serum (FBS). Using the
mean cell area as the marker for differentiation, expected
increases in cell area for cells cultured in serum-containing
LHC-9 medium occurred during the first 48 h. Adding FBS to
the LHC-9 medium resulted in a decrease in the hydrodynamic
diameter of both 5 nm CuO NPs and 35 nm CuO NPs compared
with the hydrodynamic diameter in serum-free media. The
larger, 35 nm CuO NPs exhibited differences in relative cell via-
bility with the addition of FBS. In contrast, the smaller, 5 nm
CuO NPs did not elicit changes in the cell viability when FBS
was added to the culture medium. Finally, the intracellular
Cu2þ concentration was not affected by the serum concentration
and was affected by the NP size where 35 nm CuO NPs resulted
Figure 5. Intracellular Cu2þ measured using ICP-MS. The copper concen-
tration reported is from lysed cells and was normalized to cell counts
obtained by trypan blue exclusion andmanual cell counting of a small sam-
ple of the cell digest. Values reported are the mean (n¼ 3) and error bars
represent the standard deviations of the mean; statistical analysis was per-
formed using one-way ANOVA with Tukey’s posttest and comparing each
mean to every other mean. Significant differences are noted as **p< 0.01
and ***p< 0.001. Exact p-values for all comparisons are in Table S7,
Supporting Information.
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in much higher levels of intracellular Cu2þ than 5 nm CuO NPs.
Overall, our investigation shows the importance of considering
the use of serum for cytotoxicity of various NP sizes in studies of
BEAS-2B cells.
5. Experimental Section
CuO NP Characterization and Aggregation: CuO NPs were purchased
from Sigma-Aldrich (St. Louis, MO, USA) and used without any further
modification. The morphology and average size of the particles were
obtained using transmission electron microscopy (TEM, JEOL JEM-
1230, JEOL Ltd., Akishima, Tokyo, Japan) and ImageJ.[70] TEM samples
were prepared by suspending CuO NPs in water and depositing a small
drop (5 μL) on a carbon-coated copper grid (Ted Pella, Inc., Redding, CA,
USA). The water was removed after 1 min and samples were imaged
immediately. X-ray diffraction (XRD) (Bruker, Billerica, MA, USA) was used
for elemental analysis of CuO NPs, using methods reported previously.[18]
Aggregation of CuO NPs was assessed using the hydrodynamic diam-
eter and polydispersity index (PDI) measured with a ZetaSizer Nano ZS
(Malvern Instruments, Inc., Westborough, MA, USA). For these experi-
ments, CuO NPs were suspended in LHC-9 medium (Thermo Fisher
Scientific, Waltham, MA, USA) containing varying concentrations (%v/
v) of FBS (Atlanta Biologicals, Lawrenceville, GA, USA) from 0% to 10%.
Cell Maintenance: BEAS-2B cells were purchased from ATCC
(Manassas, VA, USA) and maintained in LHC-9 medium. Cells were main-
tained in 75 cm2 tissue culture flasks coated with 0.01 mgmL1 fibronectin
from human plasma (Sigma), 0.03mgmL1 bovine collagen type I
(Sigma), and 0.01mgmL1 bovine serum albumin (BSA) (Sigma) in
LHC-9 medium. Lyophilized fibronectin was dissolved in water at
1 mgmL1 for 30 min at 37 C. It was then aliquoted into 20 μL samples
and stored at20 C until use. The coating solution was prepared in 3mL
stocks, and 1mL was added to each T75 flask. After 24 h of incubation at
37 C, the flasks were kept at room temperature and protected from light
until use. The coating was stable for up to 1 month. Prior to plating cells,
the coating solution was aspirated, and flasks were washed with 5mL of 1X
Dulbecco’s phosphate-buffered saline (DPBS). Cells were maintained in a
5% CO2 humidified atmosphere at 37 C (New Brunswick Galaxy 170S,
Eppendorf, Hauppauge, NY, USA). Subculturing was performed using
a trypsin/ polyvinylpyrrolidone (PVP) solution prepared by weighing
PVP (Sigma) and calculating the necessary volume of 0.25% trypsin-ethyl-
enediaminetetraacetic acid (EDTA) (Gibco, Life Technologies, Grand
Island, NY, USA) to form a 0.5% (w/v) PVP/trypsin-EDTA mixture, with
a target volume of 10mL. The 0.25% trypsin-EDTA was added to PVP pow-
der and was vortexed to completely dissolve the PVP. Cells were detached
from flasks using 2 mL trypsin/PVP for 5 min at 37 C and this was neu-
tralized with 8 mL of LHC-9 medium. Cells were then centrifuged at
230 g for 5 min to form a pellet. The cell pellet was completely sus-
pended in fresh LHC-9 medium, counted using trypan blue exclusion,
and seeded at 1.1 105 cells/T75 flask or 4.4 104 cells/60mmpetri dish.
Cell Differentiation: BEAS-2B cells were passaged into 60mm petri
dishes that had been coated as described earlier. Cells were allowed to
grow overnight prior to treatment with FBS-containing LHC-9 medium.
Images were obtained using an inverted fluorescent microscope (EVOS
FL cell imaging system, Thermo Fisher Scientific, Waltham, MA, USA)
at 0 h (prior to changing the media), 24 h, 48 h (media refreshed), and
72 h. The area of cells was obtained from each image using a MATLAB
script encoding Otsu’s method for image processing using a minimum
of 100 cells.[71] The mean cell area for each FBS concentration at each time
was normalized against the mean cell area at time zero. The mean ratio
and mean standard deviation are reported.
Cytotoxicity of CuO NPs In Vitro: BEAS-2B cells were seeded at 1 104
cells/well and 100 μL/well in a 96-well plate coated as described earlier and
incubated overnight. The medium was removed, and 200 μL of CuO NP
suspension or copper nitrate trihydrate (Strem Chemicals, Newburyport,
MA, USA) in LHC-9 medium (40 μgmL1 copper), with varying amounts
of FBS, was added to the plate. After 24 h of NP exposure, the mediumwas
removed and replaced with 100 μL of fresh LHC-9 medium. Then,
20 μL of 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sul-
fophenyl)-2H-tetrazolium reagent (CellTiter 96 Aqueous One solution,
Promega Corporation, Madison, WI, USA) was added to each well and
plates were incubated for 1–4 h at 37 C and 5% CO2 to allow for dye con-
version. After incubation, plates were centrifuged at 500 g for 20 min to
sediment any remaining NPs, and 70 μL of medium was removed from the
top of the wells and placed into a new 96-well plate. The absorbance of
each sample at 490 nm was obtained using a SpectraMax plate reader
(Molecular Devices, Inc., Sunnyvale, CA, USA). The absorbance was aver-
aged to the control group without any NPs or FBS in the LHC-9 medium.
Uptake of CuO NPs In Vitro: BEAS-2B cells were seeded at 2 105 cells/
dish in 60mm petri dishes (coated as previously described). Cells were
maintained at 37 C and 5% CO2 for 24 h, prior to adding 4mL of NP
suspension (10 μg mL1) in LHC-9 medium with varying amounts of
FBS. After treatment for 24 h, the medium was removed, and cells were
gently washed with 1X DPBS (Gibco) three times to remove any NPs in
suspension. Cells were removed from the petri dishes using trypsin/PVP
and centrifuged at 230 g for 5 min. The supernatant was removed, and
cells were resuspended in 1mL 1X DPBS. Small portions of each sample
(30 μL) were removed for cell counts using 0.2% trypan blue exclusion
(Sigma). After counting, cells were centrifuged again at 230 g for
5 min. The PBS was removed from the cell pellet and replaced with
100 μL of concentrated nitric acid for overnight digestion. The next day,
samples were diluted with 5 mL of 1% nitric acid and analyzed alongside
a standard curve of copper nitrate dissolved in 1% nitric acid (0–500 ppb).
The copper concentration was measured using ICP-MS (Thermo X-series
II, Thermo Fisher Scientific) with indium as the internal standard.
Statistical Analysis: The reported data are expressed as the mean 
standard deviation for independent trials, with no preprocessing.
All the data were analyzed using ANOVA with Tukey’s posttest using
GraphPad Prism software (GraphPad, Inc., La Jolla, CA, USA). A two-
way ANOVA multiple comparisons of means was used for cell viability,
a nested one-way ANOVA to compare the mean values at each FBS con-
centration was performed for mean cell area, and an ordinary one-way
ANOVA was used to compare the mean values for intracellular Cu2þ
measurements.
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